Tests predictive of thrombosis in cancer

Thrombosis Research

Volumn 125, Issue , 2010, Pages S12-S15

  Ay, Cihan ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biomarkers; Pulmonary embolism; Venous thrombosis

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSIS, MEASUREMENT AND ANALYSIS; HUMAN; NEOPLASM; REVIEW; VENOUS THROMBOEMBOLISM;

BIOLOGICAL MARKERS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; NEOPLASMS; VENOUS THROMBOEMBOLISM;

EID: 77955474743     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70005-0     Document Type: Article

References (42)

1. Lyman, GH, Khorana, AA, Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol 27:29 (2009), 4821–4826.
2. Wun, T, White, RH, Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 22:1 (2009), 9–23.
3. Khorana, AA, Connolly, GC, Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27:29 (2009), 4839–4847.
4. Ay, C, Simanek, R, Vormittag, R, Dunkler, D, Alguel, G, Koder, S, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112:7 (2008), 2703–2708.
5. Levin, J, Conley, CL, Thrombocytosis Associated with Malignant Disease. Arch Intern Med 114 (1964), 497–500.
6. Kies, MS, Posch, JJ Jr., Giolma, JP, Rubin, RN, Hemostatic function in cancer patients. Cancer 46:4 (1980), 831–837.
7. Edwards, RL, Rickles, FR, Moritz, TE, Henderson, WG, Zacharski, LR, Forman, WB, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 88:5 (1987), 596–602.
8. Sierko, E, Wojtukiewicz, MZ, Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30:1 (2004), 95–108.
9. Khorana, AA, Francis, CW, Culakova, E, Lyman, GH, Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104:12 (2005), 2822–2829.
10. Khorana, AA, Kuderer, NM, Culakova, E, Lyman, GH, Francis, CW, Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:10 (2008), 4902–4907.
11. Trujillo-Santos, J, Nieto, JA, Tiberio, G, Piccioli, A, Di Micco, P, Prandoni, P, et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 100:3 (2008), 435–439.
12. Mandala, M, Barni, S, Prins, M, Labianca, R, Tondini, C, Russo, L, et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol, 2009.
13. Simanek, R, Vormittag, R, Ay, C, Alguel, G, Dunkler, D, Schwarzinger, I, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost, 2009 in press.
14. Polgar, J, Matuskova, J, Wagner, DD, The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3:8 (2005), 1590–1596.
15. Ay, C, Jungbauer, LV, Sailer, T, Tengler, T, Koder, S, Kaider, A, et al. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 53:7 (2007), 1235–1243.
16. Blann, AD, Noteboom, WM, Rosendaal, FR, Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?. Br J Haematol 108:1 (2000), 191–193.
17. Kyrle, PA, Hron, G, Eichinger, S, Wagner, O, Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 97:6 (2007), 880–883.
18. Ay, C, Jungbauer, LV, Kaider, A, Koder, S, Panzer, S, Pabinger, I, et al. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Thromb Haemost 99:5 (2008), 899–904.
19. Rickles, FR, Edwards, RL, Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62:1 (1983), 14–31.
20. Falanga, A, Thrombophilia in cancer. Semin Thromb Hemost 31:1 (2005), 104–110.
21. Kohli, M, Fink, LM, Spencer, HJ, Zent, CS, Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul Fibrinolysis 13:1 (2002), 1–5.
22. Hanzal, E, Tatra, G, Prothrombin fragment F 1 + 2 plasma concentrations in patients with gynecologic malignancies. Gynecol Oncol 49:3 (1993), 373–376.
23. Lippi, G, Franchini, M, Targher, G, Favaloro, EJ, Help me, Doctor My D-dimer is raised. Ann Med, 2008, 1–12.
24. Seitz, R, Rappe, N, Kraus, M, Immel, A, Wolf, M, Maasberg, M, et al. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 4:2 (1993), 249–254.
25. Ay, C, Vormittag, R, Dunkler, D, Simanek, R, Chiriac, AL, Drach, J, et al. D-dimer and prothrombin fragment 1–+–2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27:25 (2009), 4124–4129.
26. Arpaia, G, Carpenedo, M, Verga, M, Mastrogiacomo, O, Fagnani, D, Lanfredini, M, et al. D-dimer before chemotherapy might predict venous thromboembolism. Blood Coagul Fibrinolysis 20:3 (2009), 170–175.
27. Cosmi, B, Legnani, C, Cini, M, Guazzaloca, G, Palareti, G, The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients. Haematologica 90:5 (2005), 713–715.
28. Sallah, S, Husain, A, Sigounas, V, Wan, J, Turturro, F, Sigounas, G, et al. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy. Clin Cancer Res 10:21 (2004), 7238–7243.
29. Tsai, AW, Cushman, M, Rosamond, WD, Heckbert, SR, Tracy, RP, Aleksic, N, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113:8 (2002), 636–642.
30. Koster, T, Blann, AD, Briet, E, Vandenbroucke, JP, Rosendaal, FR, Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:8943 (1995), 152–155.
31. Kyrle, PA, Minar, E, Hirschl, M, Bialonczyk, C, Stain, M, Schneider, B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343:7 (2000), 457–462.
32. Cosmi, B, Legnani, C, Cini, M, Favaretto, E, Palareti, G, D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Res 122:5 (2008), 610–617.
33. Yigit, E, Gonullu, G, Yucel, I, Turgut, M, Erdem, D, Cakar, B, Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. Eur J Intern Med 19:8 (2008), 602–607.
34. Auwerda, JJ, Sonneveld, P, de Maat, MP, Leebeek, FW, Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma. Haematologica 92:2 (2007), 279–280.
35. Battistelli, S, Stefanoni, M, Lorenzi, B, Dell'avanzato, R, Varrone, F, Pascucci, A, et al. Coagulation factor levels in non-metastatic colorectal cancer patients. Int J Biol Markers 23:1 (2008), 36–41.
36. Minnema, MC, Fijnheer, R, De Groot, PG, Lokhorst, HM, Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost 1:3 (2003), 445–449.
37. Dogan, M, Demirkazik, A, Konuk, N, Yalcin, B, Buyukcelik, A, Utkan, G, et al. The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. Int J Biol Markers 21:4 (2006), 206–210.
38. Vormittag, R, Simanek, R, Ay, C, Dunkler, D, Quehenberger, P, Marosi, C, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol 29:12 (2009), 2176–2181.
39. Rak, J, Milsom, C, Yu, J, Tissue factor in cancer. Curr Opin Hematol 15:5 (2008), 522–528.
40. Khorana, AA, Francis, CW, Menzies, KE, Wang, JG, Hyrien, O, Hathcock, J, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6:11 (2008), 1983–1985.
41. Tesselaar, ME, Romijn, FP, Van Der Linden, IK, Prins, FA, Bertina, RM, Osanto, S, Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5:3 (2007), 520–527.
42. Kroger, K, Weiland, D, Ose, C, Neumann, N, Weiss, S, Hirsch, C, et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 17:2 (2006), 297–303.